Sort   by:  
 Page size 
UnknownBrigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study.
Not available
S-EPMC8997056 | biostudies-literature
UnknownGenomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
Not available
S-EPMC2883967 | biostudies-literature
UnknownA whole-genome sequence and transcriptome perspective on HER2-positive breast cancers.
Not available
S-EPMC4947184 | biostudies-literature
UnknownConstitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
Not available
S-EPMC5445615 | biostudies-literature
UnknownAssessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Not available
S-EPMC5568360 | biostudies-literature
Sort   by:  
 Page size